Stuart Diamond: The Mitochondrial Triangle and VO₂ Max
Stuart Diamond, Medical Doctor at Geneva College of Longevity Science, and Co-Founder at Equilux – Unlock Your Biology, posted on LinkedIn:
“The Mitochondrial Triangle and VO₂ Max: The New Blueprint for Healthspan, Longevity and the Future of Equilux
In longevity medicine, one metric continues to predict who not only lives longer — but lives better: VO₂ max.
VO₂ max is a direct window into mitochondrial capacity, metabolic flexibility, and cellular resilience.
At Equilux, we think of it as a vital sign of biological youth.
And what’s emerging now is how three mitochondrial interventions — Urolithin A, NAD⁺ optimization, and MOTS-c — work together to strengthen the very systems that VO₂ max measures.
These aren’t random supplements.
They’re part of a coordinated mitochondrial strategy we’re integrating directly into the Equilux clinical framework.
- Urolithin A — Improving Mitochondrial Quality (Equilux: “Reset”)
Urolithin A is one of the only compounds clinically proven in humans to induce mitophagy, the cleanup process that removes dysfunctional mitochondria.
Key evidence:
- Cell Reports Medicine: Improved muscle strength and mitochondrial biomarkers in middle-aged adults.
- JAMA Network Open: Enhanced endurance and mitochondrial gene expression in older adults.
- Nature Aging: Demonstrated age-related improvements in mitochondrial and immune function via mitophagy.
At Equilux, this sits in the “Reset” phase — clearing out the mitochondrial debris that limits energy production, recovery, and VO₂ max potential.
2. NAD⁺ — Fueling the New Mitochondrial Network (Equilux: “Rebuild”)
Once broken mitochondria are cleared, NAD⁺ becomes the limiting factor for:
- Sirtuin activity (SIRT1, SIRT3)
- Mitochondrial biogenesis
- ATP output
- Oxidative metabolism
- Cellular repair and stress tolerance
White-paper-level support:
- A 2024 systematic review highlights NAD⁺ precursors improving mitochondrial density, metabolism, and cellular energetics in humans.
- Research across Nature, Cell Metabolism, and Science confirms NAD⁺ decline is a hallmark of aging — and restoring NAD⁺ restores mitochondrial function.
At Equilux, this is part of the “Rebuild” phase — supporting biogenesis and restoring youthful energetic pathways.
3. MOTS-c — Enhancing Metabolic Flexibility (Equilux: “Optimize”)
MOTS-c is a mitochondrial-encoded peptide that functions like an internal exercise signal.
Key scientific support:
- Nature Communications: Human subjects showed increased MOTS-c levels after acute exercise.
- Journal of Translational Medicine: Described MOTS-c’s role in AMPK activation, insulin sensitivity, fat oxidation, and cellular stress resilience.
- Preclinical data shows dramatic improvements in endurance, metabolic function, and healthspan.
At Equilux, we use MOTS-c in the “Optimize” phase — improving the body’s ability to use oxygen and fuel, directly influencing VO₂ max and metabolic age.”
Stay informed with Hemostasis Today.
-
Apr 20, 2026, 18:59Chokri Ben Lamine: Contributing to a Landmark Chapter on Amegakaryocytic Thrombocytopenia in Bone Marrow Failure
-
Apr 20, 2026, 18:39David McIntosh: A Watershed Moment for Global Plasma Community and Call for Unified Action
-
Apr 20, 2026, 18:15Nandini Pethe: Grateful for a Fantastic 2026 HFA Symposium Filled with Impactful Educational Sessions and Meaningful Connections
-
Apr 20, 2026, 17:13Armghan Ans: The Stroke Decision Nobody Owns
-
Apr 20, 2026, 17:12Assefa Desalew: RhD-Negative Status and Adverse Perinatal Outcomes in Eastern Ethiopia
-
Apr 20, 2026, 16:55Francesco Lo Monaco: Blood Type and Heart Risk – Small Differences, Bigger Role of Lifestyle
-
Apr 20, 2026, 16:44Supporting the Next Generation in Thrombosis and Hemostasis at ISTH 2026
-
Apr 20, 2026, 16:38Bjorn Logi Thorarinsson: Strengthening Stroke Units Through Certification, Registries, and Evidence-Based Practice
-
Apr 20, 2026, 16:37Domenico Girelli: Anemia Is Linked to Higher Dementia Risk and Elevated Alzheimer’s Disease Biomarkers